MindMap Gallery 8.3. Subarachnoid hemorrhage
Neurology - Detailed explanation of the knowledge framework of subarachnoid hemorrhage in cerebrovascular disease. Including etiology, pathogenesis, pathology, clinical manifestations, treatment, prognosis, etc.
Edited at 2023-11-12 17:30:09This is a mind map about bacteria, and its main contents include: overview, morphology, types, structure, reproduction, distribution, application, and expansion. The summary is comprehensive and meticulous, suitable as review materials.
This is a mind map about plant asexual reproduction, and its main contents include: concept, spore reproduction, vegetative reproduction, tissue culture, and buds. The summary is comprehensive and meticulous, suitable as review materials.
This is a mind map about the reproductive development of animals, and its main contents include: insects, frogs, birds, sexual reproduction, and asexual reproduction. The summary is comprehensive and meticulous, suitable as review materials.
This is a mind map about bacteria, and its main contents include: overview, morphology, types, structure, reproduction, distribution, application, and expansion. The summary is comprehensive and meticulous, suitable as review materials.
This is a mind map about plant asexual reproduction, and its main contents include: concept, spore reproduction, vegetative reproduction, tissue culture, and buds. The summary is comprehensive and meticulous, suitable as review materials.
This is a mind map about the reproductive development of animals, and its main contents include: insects, frogs, birds, sexual reproduction, and asexual reproduction. The summary is comprehensive and meticulous, suitable as review materials.
Subarachnoid hemorrhageSAH aneurysmal subarachnoid hemorrhage
Intracranial blood vessels rupture and blood flows into the subarachnoid space.
Classification
Traumatic
spontaneity
primary
It is the rupture of vascular lesions at the base of the brain or on the surface of the brain (such as congenital aneurysms, cerebrovascular malformations, microaneurysms caused by hypertensive cerebral arteriosclerosis, etc.) and blood flows into the subarachnoid space, accounting for about 10% of acute strokes. ;
Secondary
The intracerebral hematoma penetrates the brain tissue and blood flows into the subarachnoid space.
1. Causes and pathogenesis
(1) Cause of disease
1. Intracranial aneurysm
It is the most common cause (accounting for about 75% to 80%). Among them, congenital miliary aneurysms account for about 75%, and fusiform aneurysms caused by hypertension, atherosclerosis, and fungal aneurysms caused by infection can also be seen.
2. Vascular malformations
It accounts for about 10% of the causes of SAH, of which arteriovenous malformations (AVMs) account for 80% of vascular malformations. More common in young people, more than 90% are located in the supratentorial area, often in the distribution area of the middle cerebral artery.
3.Others
Such as moyamoya disease (accounting for 20% of SAH in children), intracranial tumors, pituitary apoplexy, blood system diseases, intracranial venous system thrombosis and complications of anticoagulation therapy, etc. In addition, about 10% of patients have unknown causes
(2) Pathogenesis
1. Aneurysm
2. Cerebral arteriovenous malformation
2. Pathophysiology
Common causes: Aneurysm
blood enters subarachnoid space
stimulate pain sensitive structures
Headache
Intracranial pressure (↑)
aggravate headache
retinal hemorrhage
brain herniation
disorder of consciousness
Blood clot blocks cerebrospinal fluid circulation pathway
CSF circulation disorder
acute obstructive hydrocephalus
communicating hydrocephalus
inflammatory mediators
Intracranial pressure (↑)
chemical meningitis
vasoactive substances
Vasospasm
cerebral infarction
Blood and breakdown products
hypothalamus
dysfunction
Fever
elevated blood sugar
acute myocardial ischemia
Arrhythmia
3. Clinical manifestations
(1) General symptoms
1.Headache
The typical manifestation of aneurysmal SAH is a sudden, extremely severe, full-body headache. Patients often describe the headache as "the worst headache they have ever experienced in their life." The headache cannot be relieved or is progressively worsening.
It is often accompanied by transient disturbance of consciousness, nausea and vomiting.
Localized headaches often indicate the location of a ruptured aneurysm
The headache of aneurysmal SAH lasts for several days and gradually decreases after 2 weeks. If the headache worsens again, it often indicates that the aneurysm is bleeding again. However, SAH headaches caused by arteriovenous malformation rupture are often not severe.
2. Meningeal irritation sign
Cervical ankylosis, Kernig's sign, Brudzinski sign and other meningeal irritation signs, with cervical ankylosis being the most common
3. Eye symptoms
Subvitreous patchy hemorrhage can be seen in the fundus of 20% of patients, which is caused by acute increase in intracranial pressure and obstruction of ophthalmic vein return.
4. Psychiatric symptoms
5. Other symptoms
Some patients may develop symptoms such as cerebral heart syndrome, gastrointestinal bleeding, acute pulmonary edema, and localized neurological deficits.
(2) Localization symptoms of aneurysm
1. Aneurysm of cavernous sinus segment of internal carotid artery
Patients have forehead and eye pain, vascular murmurs, exophthalmos, and eye movement disorders caused by damage to cranial nerves III, IV, VI, and V1, and their rupture can cause internal carotid artery cavernous sinus fistula.
2. Internal carotid artery-posterior communicating artery aneurysm
Patients presenting with oculomotor nerve compression often suggest posterior communicating artery aneurysm
3. Middle cerebral aneurysm
Symptoms such as hemiplegia, aphasia, and convulsions in patients often indicate that the aneurysm is located at the first branch of the middle cerebral artery.
4. Anterior cerebral artery-anterior communicating artery aneurysm
The patient's symptoms such as psychiatric symptoms, unilateral or bilateral lower limb paralysis, and disturbance of consciousness suggest that the aneurysm is located in the anterior cerebral artery or anterior communicating artery.
5. Posterior cerebral aneurysm
The patient presented with homonymous hemianopsia, Weber syndrome, and III cranial nerve palsy.
6. Vertebro-basilar aneurysm
Patients may experience symptoms such as occipital and facial pain, hemifacial spasm, facial paralysis, and brainstem compression.
(3) Localization symptoms of vascular malformations
The incidence of arteriovenous malformations in men is twice as high as in women, and most cases occur between the ages of 10 and 40. Common symptoms include epileptic seizures, hemiparesis, aphasia or visual field defects, etc., which has localization significance.
(4) Common complications
1.Rebleeding
It refers to the recurrence of severe headache, vomiting, epileptic seizures, coma or even decerebrate tonic attacks after the condition has stabilized. Cervical ankylosis and Kernig's sign are aggravated. The cerebrospinal fluid is bright red upon review. 20% of patients with aneurysms may experience rebleeding 10 to 14 days after the disease, approximately doubling the mortality rate
2. Cerebral vasospasm CVS
Delayed vasospasm begins to occur 3 to 5 days after illness, peaks at 5 to 14 days, and gradually disappears in 2 to 4 weeks. TCD or DSA can help confirm the diagnosis.
3. Acute or subacute hydrocephalus
Caused by blood entering the ventricular system and subarachnoid space to form blood clots that block the cerebrospinal fluid circulation pathway.
In mild cases, signs such as drowsiness, slow thinking, impaired short-term memory, limited upward vision, abducens nerve paralysis, and hyperreflexia of lower limb tendons may occur.
Severe cases can cause intracranial hypertension and even cerebral herniation.
Subacute hydrocephalus occurs weeks after onset and is characterized by insidious dementia, gait abnormalities, and urinary incontinence
4. Auxiliary inspection
(1) Head CT
Head CT scan is the first choice for clinically suspected SAH.
(2) Brain MRI
When the sensitivity of CT examination decreases a few days after the onset of SAH, MRI can play a greater role.
Especially when the bleeding is on the surface of the brain, MRI is more sensitive than CT and can show the location of the bleeding.
In patients with confirmed SAH but negative DSA, MRI is used to detect other causes of SAH.
When no cause of bleeding is found in the brain, spine MRI should be performed to rule out spinal cord cavernous hemangioma or arteriovenous malformation.
(3) CT angiography (CTA) and MR angiography (MRA)
(4) DSA
DSA is still the gold standard for clinical diagnosis of aneurysm.
Generally, it is advisable to proceed within 3 days or 3 weeks after bleeding.
(5) Lumbar puncture
If the CT scan result is negative, a lumbar puncture for CSF examination is strongly recommended. Usually, if the diagnosis has been confirmed by CT examination, lumbar puncture is not used as a routine clinical examination.
Homogeneous bloody CSF is a characteristic manifestation of SAH.
(6)TCD
Can be used as a non-invasive technique to monitor cerebral vasospasm after SAH
(7) Others
Routine blood tests, coagulation function, and liver function tests can help find other causes of bleeding; electrocardiogram can show abnormalities such as high peaks or obvious inversion of T waves, shortened PR intervals, and high U waves.
5. Diagnosis and differential diagnosis
(1) Diagnosis (P218)
symptom
Sudden severe headache
Vomit
disorder of consciousness
physical signs
Positive meningeal irritation sign
No focal neurological signs
Auxiliary inspection
CT confirms cisterns and cobwebs
Submembranous space hyperdensity sign
lumbar puncture bloody cerebrospinal fluid
(2) Differential diagnosis
Hypertensive cerebral hemorrhage
★Key points in identifying subarachnoid hemorrhage and cerebral hemorrhage
Intracranial infection
brain tumor
other
6. Treatment
The purpose of acute phase treatment is to
① Prevent and treat further bleeding,
② Reduce intracranial pressure,
③ Prevent and treat secondary cerebral vasospasm,
④ Reduce complications,
⑤Look for the cause of bleeding,
⑥ Treat the primary disease
⑦ Prevent recurrence
The selection of surgical treatment and judgment of prognosis are mainly based on the clinical grade of SAH, and generally the Hunt-Hess classification can be used.
(1) General processing
1. Keep vital signs stable
2. Reduce high intracranial pressure
Dehydrating agents are mainly used, such as mannitol, furosemide, glyceryl fructose or glycerol sodium chloride. Albumin can also be used as appropriate.
3. Avoid exertion and emotional fluctuations and keep bowel movement smooth.
Those who are irritable are given sedatives, and those who have headaches are given analgesics. Be careful when using aspirin and other non-steroidal anti-inflammatory analgesics that may affect coagulation function, or morphine, pethidine and other drugs that may affect respiratory function.
4. Other symptomatic and supportive treatments
This includes maintaining water and electrolyte balance, providing high-fiber and high-energy diets, strengthening nursing care, and paying attention to preventing urinary tract infections and aspiration pneumonia, etc.
(2) Prevent further bleeding
1. Absolute bed rest: 4 to 6 weeks
2. Regulate blood pressure
Prevent excessive blood pressure from causing further bleeding, and pay attention to maintaining cerebral perfusion pressure.
Generally, systolic blood pressure should be controlled below 160mmHg.
If mean arterial pressure >125mmHg or systolic blood pressure>180mmHg
Short-acting and safe antihypertensive drugs can be continuously infused intravenously under blood pressure monitoring
It is best to use antihypertensive drugs such as nicardipine, labetalol and esmolol
If the patient develops acute neurological symptoms
It is best not to choose sodium nitroprusside
Sodium nitroprusside has the adverse reaction of increasing intracranial pressure, and long-term infusion may cause poisoning.
3. Antifibrinolytic drugs
SAH does not have the hemostatic effect of compressing brain tissue, so hemostatic drugs can be used appropriately.
4. Surgical and endovascular treatment of ruptured aneurysms
Clamping or endovascular treatment are the most effective treatments for preventing rebleeding in SAH.
(3) Prevention and treatment of cerebral vasospasm
Oral nimodipine can effectively reduce adverse outcomes caused by SAH
nimodipine
① Used to improve blood circulation during the recovery period of acute cerebrovascular disease. Cerebral vasospasm after various causes of subarachnoid hemorrhage, and resulting ischemic neurological disorders, hypertension, migraine, etc.
②Also used as ischemic neuron protection and treatment of vascular dementia.
③It also has certain effects on sudden deafness.
Prevention and treatment of cerebral vasospasm should begin during the early management phase of ruptured aneurysms
In the presence of delayed cerebral ischemia, treatment with elevated blood pressure is recommended.
Possible treatments for symptomatic cerebral vasospasm
is cerebral angioplasty and/or selective intra-arterial vasodilator therapy, Especially if you haven’t seen quick results after treatment to raise your blood pressure.
(4) Treatment of hydrocephalus
Symptomatic hydrocephalus in acute phase of SAH
cerebrospinal fluid shunt treatment
Chronic symptomatic hydrocephalus after SAH
A permanent cerebrospinal fluid shunt was performed.
(5) Prevention and treatment of epilepsy
If the patient has the following risk factors, such as a history of epileptic seizures, parenchymal hematoma, cerebral infarction, or middle cerebral artery aneurysm, it may be considered
(6) Treatment of hyponatremia and hypovolemia
Isotonic fluids can be used to correct hypovolemia, and fludrocortisone acetate and hypertonic saline can be used to correct hyponatremia.
(7) Cerebrospinal fluid injection therapy
Releasing 10~20ml of CSF each time, twice a week, can promote blood absorption and relieve headaches, and may also reduce the occurrence of cerebral vasospasm and hydrocephalus. However, we should be alert to the risks of brain herniation, intracranial infection, and rebleeding.
7. Prognosis
The overall prognosis of SAH is poor, with a mortality rate as high as 45% and a high disability rate among survivors.